AUCTORES
Globalize your Research
Mini-Review
*Corresponding Author: Imteyaz Qamar, School of Biotechnology, Gautam Buddha University, Greater Noida, U.P. -201312, INDIA.
Citation: M Anas, P Banerjee, N Singh, I Qamar. (2021) Mechanistic Insights into Immunological Therapy for Targeting Diabetic Retinopathy. Journal of Endocrinology and Disorders. 5(3): Doi:10.31579/2640-1045/073
Copyright: © 2021 Imteyaz Qamar. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 26 April 2021 | Accepted: 01 May 2021 | Published: 03 May 2021
Keywords: diabetic retinopathy; anti-vascular endothelial growth factors; Neovascularization; diabetic macular edema; leukostasis; Inflammation; NSAIDs
Diabetic retinopathy (DR) is a common complication amongst patients that have diabetes. It is a leading cause of blindness in middle age people. A large proportion of patients who have diabetes develop retinopathy. There are several immunological reasons associated with the pathophysiology of this disease. Role of several mediators that increase the oxidative stress and have a pro-inflammatory effect which leads to capillary occlusion and neovascularization (NV). Increased vasopermeability due to disruption of the blood-retinal barrier (BRB) leading to diabetic macular edema (DME). Immunotherapies utilise different compounds and target various inflammatory molecules like TNF-α and pathways such as PPARγ for treatment of this progressive disease. Inflammatory and pro-inflammatory pathways are found to have an essential role in promoting DR; therefore, targeting them provides a useful technique for curing DR.
The current statistical data suggests that India would be regarded as diabetic capital in the near future. According to Kaveeshwar and Cornwall (2014), reported 31.7 million confirmed cases of diabetes mellitus (DM) in India in the year 2000. The mentioned figure is estimated to rise to 79.4 million by 2030, the largest number in any country in the world. Almost all types of diabetics, either Type 1 DM or Type 2 DM, are expected to develop diabetic retinopathy (DR) in the long run [1]. Diabetes constitutes a group of metabolic disorders that share a common characteristic feature of hyperglycemia, i.e., elevated glucose level in the blood. This could be of two types: type 1 DM where insulin is deficient or type 2 DM characterized by variable degrees of insulin resistance in the cells, impaired insulin secretion from islet cells of the pancreas and/or glucose over-production. If this hyperglycemic state is not controlled, the chronic exposure can give rise to various complications — nephropathy, neuropathy and retinopathy [2]. Amongst the various ocular complications caused by DM, Diabetic retinopathy is the most commonly observed preventable cause of blindness. Other ocular complications from DM include glaucoma, cataract and ocular surface diseases.
Diabetic retinopathy (DR) is microangiopathy, i.e. pathology in small retinal vessels like arterioles, venules and capillaries. Features of DR include retinal capillary occlusion and leakage, breaking the blood-retinal barrier; hence, exudate formation due to leakage of leaked lipoproteins. This is followed by neovascularization [3]. In the initial days of Diabetic retinopathy, patients are mostly asymptomatic. Symptoms might start precipitating as the microangiopathy progresses. In such cases, symptoms observed are like blurred vision, floaters and flashes, distorted vision, and in later stages, there could be partial or even total loss of vision.
The most common reason for the loss of vision in patients with DR is diabetic macular edema (DME). DME is characterized by swelling or thickening of the macula due accumulation of fluid in the macula because of the breakdown of the blood-retinal barrier [4]. DME can occur at any DR stage, which can lead to distortion of visual images and a reduction in visual acuity [5].
Presently, the treatment plans for diabetic retinopathy aim at managing the microvascular complications by intravitreal pharmacologic agents, laser photocoagulation and vitreous surgery.
Anti-VEGF (vascular endothelial growth factors) agents are the most used intravitreal agent nowadays to manage both early and advanced stages of DR. Although conventional laser therapy provides stabilization of visual acuity, anti-VEGF therapy can help in developing visual improvement with less ocular adverse effects [6]. Here, immunological therapy is discussed for targeting diabetic retinopathy.
PATHOPHYSIOLOGY
A number of factors are involved in the progression of diabetic retinopathy. These factors can be genetic, epigenetic, or environmental, which makes the development of DR quite complex. The main contributing factors in pathogenesis are elevated blood sugar levels (Hyperglycemia), hyperlipidemia, hypertension, neuronal dysfunction and inflammation [7]. Dysfunctioning of different retinal cells such as glial, muller, ganglion, endothelial cells, etc. are also engaged in this process [6]. The dysfunctioning of blood microcapillaries in the retina can lead to an increase in its membrane permeability followed by its obliteration. The breakdown of the blood-retinal barrier (BRB) will lead to macular edema and formation of abnormal new blood vessels (Neovascularization). The major factor responsible for structural and functional changes associated with DR is the elevated level of glucose concentration in the blood. Hyperglycemia causes advanced glycation end products (AGEs) formation, protein kinase C activation, increase in oxidative stress and promotes the polyol pathway [8]. AGEs and its receptor have a pro-inflammatory effect and increase the neurodegenerative process [9]. AGEs also play a part in the protein kinase C activation that is responsible for processes such as occlusions in the capillary, increase in oxidative stress, production of pro-inflammatory proteins and elevated vasopermeability [10]. Hyperglycemia activates reactive oxygen species (ROS) that damage the retinal cells, further stimulating cellular damage [11].
Inflammation in DR:
Inflammation and many pro-inflammatory compounds like vascular endothelial growth factor, different cytokines, chemokines, angiotensin II, eicosanoid, etc. have an additive effect in the pathogenesis of diabetic retinopathy [12]. Microvascular inflammation leads to diabetic macular edema (DME), blockage in blood supply to tissues leading to hypoxic condition (ischemia), and formation of abnormal new blood vessels [13]. Recent studies infer that VEGF is affiliated to ICAM-1 upregulation and is able to induce conformational changes in tight junctions of the endothelial cells which may result in endothelial cell disruption and leukostasis as VEGF is the robust vasoactive factor that induces angiogenesis and increase the vascular permeability [14]. Sustained hyperglycemia and hypoxia can induce VEGF upregulation because of vasoconstriction and capillary loss. Retinal cells like Muller cells, ganglions, endothelial cells, and pericytes are highly active in response and metabolism; therefore, they may have a part in producing VEGF as reported by some studies [15]. DR patients have been observed with high levels of TNF-α, which is a pro-inflammatory cytokine in the ocular fibrovascular membranes. Also, in the vitreous samples from the DR patients, upregulated levels of chemokines have been observed such as CCL5, CCL2, CXCL12, CXCL8 and CXCL10. Studies suggest that the increased levels of the inflammatory molecules such as TNF-α, IL-1β, CXCL12 and CCL5 contribute to the pathogenesis of DR [16].
Macular edema and vascular leakage:
Diabetic macular edema (DME) or simply macular edema is a result of blood-retinal barrier disruption which consists of inner barrier and the outer barrier. The impairment of the BRB is carried out by several vasoactive factors. Increased vasopermeability due to distortion of tight junctional complexes between endothelial cells in the retina and vascular leakage is promoted by VEGF, resulting in extracellular accumulation [17]. BRB breakdown is boosted by PKC, which further increases the vasopermeability and encourages VEGF activation. The responsibility to maintain the inner BRB and provide vascular stability is carried out by pericytes. Dysfunctioning or loss of pericytes will evidently disturb the integrity and working of the inner BRB, which will lead to microaneurysm formation, increased vasopermeability and capillary dilatation [18].
Retinal ischemia and neovascularization:
The occlusion in blood capillaries stimulates retinal nonperfusion, which leads to neovascularization. In diabetic patients, increased levels of VEGF play a key role in vascular obstruction leading to ischemia through complex mechanisms. This level of VEGF can be reduced subsequently by pan-retinal photocoagulation. When leukocytes adhere to retinal vessels, it can cause endothelial cell death, vascular blockage and loss of pericyte. This pro-angiogenic mechanism is known as retinal vessel leukostasis. Neovascularization in the retina may also be intensified by a pro-angiogenic factor that is a platelet-derived growth factor (PDGF) [13].
IMMUNOTHERAPIES
Immunotherapy infers to a kind of therapy or treatment that is utilised for stimulating the immune system of a person for treating a certain disease. DR is a chronic sight-threatening disease and current treatment measures adopted for its remedy stay ineffective to an extent. Current strategies employ the use of treatments like laser photocoagulation, pan-retinal photocoagulation, intravitreal injections, intravitreal anti-VEGF, etc. Due to the lack of efficacy of these treatment methods, scientists are carrying out research to understand the immunological insights of this disease and to take advantage of this knowledge which can help in designing a robust strategy for the immunotherapy of DR.
Intravitreal Corticosteroids:
For the treatment of DME in DR intravitreal corticosteroids are being used where there is a negligible response to anti-VEGF therapy [19]. Corticosteroids are potent anti-inflammatory agents that can target large spectra of mediators that are involved in the progression of DME like chemokines, leukostasis, VEGF, TNF-α, and phosphorylation of tight-junction proteins. The treatment of DME includes dexamethasone intravitreal implant, fluocinolone acetonide intravitreal implant and off label triamcinolone acetonide [6].
Non-Steroid Anti-Inflammatory Drugs (NSAIDs):
NSAIDs have an anti-inflammatory effect and inhibit the formation of eicosanoid mediated by cyclooxygenase (COX) enzyme [20]. The NSAIDs target the COX enzymes. Mainly the COX-2 enzyme is active at the sites of inflammation and stimulates the production of pro-inflammatory factors such as PGE2α and PGF2. The inhibition of this enzyme downregulates the production of PGE2 and further reduces the inflammatory reactions induced due to diabetes. Aspirin and salicylate-based drugs, i.e., NSAIDs had a beneficial effect in reducing the incidence of diabetic retinopathy as reported in clinical studies [6].
Anti-Inflammatory Pathways:
Diabetes induces the upregulation of the pro-inflammatory pathways to exaggerate the retinal inflammation. This retinal inflammation is further enhanced by the impairment of endogenous anti-inflammatory mechanisms like the proliferator-activated receptor (PPAR)γ pathway. Impaired PPARγ is a sign of DR in DR patients, as observed in scientific studies [21]. During Inflammation, inflammatory cytokines induce oxidative stress and stimulate the expression of other molecules involved in inflammation. Therefore, inhibition of the inflammatory cytokines results in downregulating the oxidative stress and pathogenesis of DR in experimental models [22].
Blocking of RAS:
The renin-angiotensin system is involved in diabetic as well as hypertension-induced retinal inflammation. The RAS pathway has crosstalk with many other pathways of AGEs and oxidative stress. Animal models induced with diabetes had shown to prevent vascular damage, oxidative stress and inflammation when the specific blockade of the RAS was performed [23].
Blocking the Inflammatory molecules:
TNF-α is a key molecule for inflammatory reactions as it induces the formation of ROS, activates NF-κB pathway and upregulates the adhesion molecules expression like ICAM1 on the endothelial surface, which results in the recruitment of leukocytes. Therefore, TNF-α was targeted to study the anti-TNF-α therapy in the model animals induced with diabetes and some clinical cases. TNF-α trap (a soluble TNF-α receptor/Fc construct, Etanercept) was subcutaneously administered in diabetic rats and it significantly blocked the retinal inflammation, reduced the retinal cell injury and vascular leakage [24]. In clinical trials, a TNF-α neutralizing antibody was used, which improved visual acuity and reduced macular thickness in the patients [25]. Anti-CD49a neutralizing antibody targets the VLA-4 via blocking leukocyte recruitment which reduces levels of TNF-α, VEGF, vessel leakage and leukostasis [26].
Anti-Inflammasome therapy:
Inflammasomes are innate immune system receptors that have a significant role in inflammation. The inflammasomes include a central protein, an adaptor protein called apoptosis speck-like protein (ASC) and caspase-1 protein. Caspase -1 induces maturation of cytokines like IL-β and IL-8 that causes inflammation. The inflammasomes such as NLRP1, NLRP3, NLRC4 and AIM2 have a role in pathogenesis in various disorders including diabetic retinopathy and glaucoma [27]. The compound methylene blue has been identified to be effective in controlling diabetic retinopathy by inhibiting inflammasome NLRP3 [28]. Vitamin D3 (Cholecalciferol) dampens the activity of NLRP3 by the reduction of ROS and aids in intervention for DR [29]. Type 1 Interferons can inhibit the NLRP3 inflammasomes by reducing the IL-1β which inhibits NLRP1b via IL-10R and STAT3 signaling [27].
DR is retinopathy occurred in the retina due to diabetes. Diabetes is a group of metabolic disorders with a general phenotype of uncontrolled and unhealthy high blood glucose levels or hyperglycemia. Chronic hyperglycemia can lead to the pathogenesis of DR. It is fundamentally microangiopathy in small retinal vessels leading to vascular endothelial dysfunction [30].
Many metabolic pathways are adversely affected due to hyperglycemia and lead to retinopathy.
1. Increased polyol pathway: When glucose becomes excessive in the body system, it is reduced to sorbitol by the activation of the polyol pathway. Normally, this sorbitol is converted to fructose by the action of dehydrogenase enzyme in order to cross cell membranes. But due to the high glucose concentration, production of sorbitol also becomes higher, and this sorbitol gets accumulated because of enzymatic limitation. This accumulated sorbitol causes osmotic damage to retinal cells [31].
2. Protein kinase C (PKC) pathway activity: This pathway is triggered by an increased amount of DAG or Di-acyl glycerol. This activates PKC, which further enhances permeability and upregulation of vascular endothelial growth factors (VEGF) in the retina [32]. These two things affect retinal hemodynamics and abnormal neovascularization.
It is also responsible for leukostasis (abnormal clumping of leukocytes) causes capillary occlusion [33].
3. VEGF itself is an important parameter that leads to major microvascular complications of DM. Normally, it is produced by Retinal epithelial cells, pericytes and Mueller cells of the retina. The production is increased in hypoxic condition as a compensatory mechanism causing neovascularization. This increased intravitreal VEGF is also a factor responsible for DME, i.e. Diabetic macular edema [34].
4. Chronic oxidative damage or high amount of reactive oxygen species also facilitate microvascular complications.
These whole sequences of events also cause the release of inflammatory mediators in the retina, and patients usually suffer from chronic inflammation [35].
Patients may be apparently asymptomatic in initial stages but later may complain of blurred vision, floaters and flashes, dark areas in vision, impaired colour vision and in advanced disease, there could be partial to a total loss of vision.
In recent times, DR is classified into two categories— 1. non-proliferative diabetic retinopathy (NPDR) or 2. Proliferative diabetic retinopathy (PDR). These two categories are provided by Early treatment diabetic retinopathy study (ETDRS) classification. It is based on clinical findings like microaneurysms, intraretinal haemorrhages, venous abnormalities such as beading, intraretinal microvascular abnormalities (IRMA), and neovascularization (NV) [3].
1. NPDR:
- In Mild (NPDR), There are a few microaneurysms; most of these patients are reviewed annually. The review may vary from 6-12 months, depending upon the severity of signs and systemic factors.
- Moderate NPDR: less than 20 microaneurysms. Hard yellow exudates, cotton wool spots, and venous beading may also be present, but these findings are confined to the only quadrant. Every six months of review is recommended in this case.
- Severe NPDR: It is identified as any of following clinic features; Microaneurysms in all four quadrants; Venous beading in two or more quadrants; IRMA in one or more quadrants. The review is done every four months.
-Very severe NPDR: This category includes two or more of the criteria for severe NPDR. Every 2-3 months review is required.
2. PDR
- It is mostly based on neovascularization of the disc (NVD) and neovascularization elsewhere (NVE) [3].
- Due to ischemia (caused by leukocytic occlusion, inflammation and above discussed factors), NV is seen to develop and grow at the optic nerve (NVD) and elsewhere in the retina except the optic disc (NVE). In other words, NV develops at the border zone of the perfused and non-perfused retina [36].
- There are three categories of PDR provided by ETDRS classification.
- mild to moderate: If NVD is present in less than one-third disc area and NVE is in less than half-disc area. Here, treatment should be planned according to the severity of signs, the patient's systemic factors and personal circumstances. If it is left untreated, every two months review is advised.
- High risk: if NVD is in more than 1/3 area or Any NVD with vitreous or pre-retinal haemorrhage or NVE >1/2-disc area with vitreous or pre-retinal haemorrhage. Such patients require treatments as per the surgeon's/ophthalmologist's evaluation and surgical plan. Possible treatment courses include laser photocoagulation, intravitreal Anti VEGF or/and triamcinolone, pars plana vitrectomy and lipid-lowering drugs.
- Advanced diabetic eye disease: features of this category are Preretinal (retro-hyaloid) and/or integral haemorrhage, Tractional retinal detachment, Tractional retinoschisis, Rubeosis iridis (iris neovascularization). In these patients, 'Pars plana vitrectomy' is recommended [37].
AGEs- Advanced Glycation End products
BRB- Blood Retinal Barrier
COX- Cyclooxygenase
DM- Diabetes Melitus
DME- Diabetic Macular Edema
DR- Diabetic Retinopathy
ETDRS- Early Treatment Diabetic Retinopathy Study
ICAM1- Intercellular Adhesion Molecule 1
IRMA- Intraretinal Microvascular Abnormalities
MMP- Matrix Metallopeptidase
NPDR- Non-Proliferative Diabetic Retinopathy
NSAID- Non-Steroidal Anti-Inflammatory Drug
NV- Neovascularization
NVD- Neovascularization of the Disc
NVE- Neovascularization Elsewhere
PDGF- Platelet-derived Growth Factor
PDR- Proliferative Diabetic Retinopathy
PKC- Protein Kinase C
RAS- Renin-Angiotensin System
ROS- Reactive Oxygen Species
TNFα- Tumor Necrosis Factor α
VEGF- Vasoactive Endothelial Growth Factor
VLA- Very Late Antigen
We thank our authors from Gautam Buddha University who provided insight and expertise that greatly assisted the study. This review was not supported by any grant.
CONFLICTS OF INTEREST
The author declares no conflicts of interest.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
